BioNTech (NASDAQ:BNTX) Receives Buy Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a $138.00 target price on the stock. Several other research firms have also recently issued reports on BNTX. The Goldman Sachs Group assumed coverage on BioNTech in a […]
HC Wainwright reiterated their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a $138.00 target price on the stock. Several other research firms have also recently issued reports on BNTX. The Goldman Sachs Group assumed coverage on BioNTech in a […]
